Navigation Links
Byetta Lawsuit - Claims Move Forward, as Panel Considers Consolidation of Federal Claims Involving Byetta and Similar Diabetes Drugs, Bernstein Liebhard LLP Reports
Date:7/26/2013

ll of the Byetta lawsuits filed thus far allege the drug’s manufacturers concealed the association between Byetta and pancreatic cancer, and failed to provide adequate warnings regarding its risks.

Over the past several months, the entire class of incretin mimetics, including Byetta, have been the subject of mounting safety concerns, amid a growing body of evidence that indicates they could have harmful effects on the pancreas. In 2008, for example, the U.S. Food & Drug Administration (FDA) issued a Byetta pancreatitis warning after receiving a high number of reports of the disorder in users of the drug.* In February 2011, research published in Gastroenterology suggested a risk of pancreatic cancer among Byetta users, reporting that the drug appeared to increase the likelihood for the disease by nearly 3-fold. The same study also reported 30 cases of thyroid cancer and a six-fold increase risk for pancreatitis among Byetta users.**

In February 2013, a paper published in JAMA Internal Medicine reported that drugs like Byetta appeared to double the risk for pancreatitis.*** On March 14, the U.S. Food & Drug Administration (FDA) announced it was investigating findings from an unpublished study that suggested Byetta and other incretin mimetics could be associated with pre-cancerous cellular changes in the pancreas called pancreatic duct metaplasia.**** Then in April, the Institute for Safe Medicine Practices (ISMP) published an analysis of FDA adverse event reports that revealed incretin mimetics were 25 times more likely to be linked to pancreatic cancer compared to other diabetes drugs. During a 12 month period that ended in June 2012, the ISMP tallied 263 reports of pancreatitis, 71 instances of pancreatic cancer, and 14 cases of thyroid cancer among Byetta users.***** Most recently, a review of regulatory data conducted by the British Medical Journal revealed unpublished data pointing to “unwanted proliferative or inflammatory pancreatic ef
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
2. Byetta Pancreatic Cancer Allegation Lawsuits Offered through Resource4thePeople
3. DrugRisk Announces Launch of Byetta Cancer Resource Center
4. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
5. DrugRisk Update: New Study Warns of Cancer in Byetta Side Effects
6. Byetta Lawsuit News: Woman Alleges Her Thyroid Cancer Is Linked to Byetta Use, Rottenstein Law Group LLP Reports
7. DrugRisk Update: Byetta Maker Agrees With Transferring Lawsuits to Federal Court
8. Byetta Lawyers at Gilman Law, a Leading Pharmacy Law and Defective Drug Plaintiffs’ Law Firm, Troubled by Growing Byetta Pancreatic Cancer Reports
9. Diabetes Drug Byetta Caused Arkansas Man’s Pancreatic Cancer and Resulting Injuries, Alleges Lawsuit Filed by Parker Waichman LLP and Co-Counsel
10. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza
11. Byetta Pancreatic Cancer Lawsuit News: Bernstein Liebhard LLP Comments on BMJ Investigation Finding Incretin Mimetic Risks Were Downplayed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... intensive effort to sterilize feral cats reduced the number of ... a new study reveals. "We investigated whether we ever ... control," Dr. Julie Levy, a professor of shelter medicine at ... a university news release. "Neutering a few cats ... "so we wanted to pick a focused area and throw ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 A national leader ... into new offices with room to grow. , Headquarters for ... to a 60,000-square-foot office building at 8516 N.W. Expressway in ... named one of the Oklahoma’s best places to work by ... The company has hired 120 in the past two years, ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Home ... of in-home care for seniors, is proud to announce ... Series. The upcoming webinar will feature Dr. Suzanne Steinbaum, ... Lenox Hill Hospital in New York City, National Spokesperson ... author. The webinar will cover the issues surrounding women ...
(Date:8/22/2014)... (HealthDay News) -- Inner city children have a higher-than-normal risk ... followed 516 inner city children in four U.S. cities -- ... until age 5 and found that at least 10 percent ... Because only the three most common types of food ... inner city youngsters with food allergies may be even higher, ...
(Date:8/22/2014)... severe disabilities and multiple chronic conditions are screened for ... or no chronic conditions, a new study has found. ... with moderate disabilities or women with only one chronic ... with the Li Ka Shing Knowledge Institute of St. ... often have other measures of social vulnerability, such as ...
Breaking Medicine News(10 mins):Health News:Neutering Project Curbed Feral Cat Population 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Food Allergies More Common Among Inner City Kids, Study Finds 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2
... cardiologists have uncovered how a specific protein,s previously unsuspected role ... diabetes. Investigators in the mouse study also have found a ... The new research, available online and published in the March ... was carried out in the laboratory of Dr. Joseph ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... U.S. federal judge to block a government mandate calling for ... they are determined to fight back and keep the rule ... we can to warn young people about the dangers of ...
... Reinberg HealthDay Reporter , THURSDAY, March 1 (HealthDay ... cutting their risk of developing the deadly skin cancer melanoma, ... vitamin A called retinol could be a protective agent against ... researchers say. "We found a protective effect from supplemental ...
... years after the first sulfa drugs helped to revolutionize ... Children,s Research Hospital scientists have determined at an atomic ... The discovery provides the basis for a new generation ... to resist and cause fewer side effects. The ...
... Winship Cancer Institute of Emory University have identified a new ... cancer. Scientists had known that the gene, which encodes ... control proliferation and division. A team led by Erwin Van ... the process by which growing cancers attract new blood vessels. ...
... and surgeons are among the first in the nation ... injecting an investigational viral vector into their tumor. The ... Company, Tocagen Inc. "This clinical trial targets glioblastoma ... said principal investigator Santosh Kesari, MD, PhD, director of ...
Cached Medicine News:Health News:Cardiologists identify mechanism that makes heart disease worse in diabetics 2Health News:U.S. Will Push to Have Graphic Warnings on Cigarettes 2Health News:U.S. Will Push to Have Graphic Warnings on Cigarettes 3Health News:Vitamin A Supplements Might Cut Melanoma Risk: Study 2Health News:Vitamin A Supplements Might Cut Melanoma Risk: Study 3Health News:Solving mystery of how sulfa drugs kill bacteria yields 21st century drug development target 2Health News:Solving mystery of how sulfa drugs kill bacteria yields 21st century drug development target 3Health News:New pathway found for regulation of blood vessel growth in cancer 2Health News:UC San Diego among first in nation to treat brain cancer with novel viral vector 2
(Date:8/21/2014)... DEERFIELD, Ill. , Aug. 21, 2014 /PRNewswire/ ... reports Baxter International Inc. today announced positive results ... BAX 855, an investigational, extended half-life recombinant factor ... ADVATE [Antihemophilic Factor (Recombinant)], which met its primary ... the prophylaxis arm compared to the on-demand arm. ...
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe customer ... , Managing Partner and Healthcare Industry Group Leader, has ... which recognizes the most inspiring people in the life-sciences ... in research and development, marketing, technology, creativity, strategy and ... 2006 as a partner in its leading Rosetta Consulting ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
Breaking Medicine Technology:Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Shannon Hartley Shines in PharmaVOICE 100 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... and helix provide distal shaft column ... Construction eliminates springback and provides for ... to provide a better fit for ... ,Trimmable ends provide a custom ...
... The AMS 650™ and 600M™ malleable penile ... patientsespecially those with limited dexterity. These implants ... the patient to position them in an ... the penis rigid enough for sexual intercourse ...
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Only Mentors reusable Alpine Leg Bag has patented Kraylex odor barrier, offset port options, and integrated loops providing total confidence and comfort....
Medicine Products: